Biopharmaceutical Analysis

Feliza Mirasol is the science editor for 

Videos

At AAPS PharmSci 360.Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed trends in new analytical tools for RNA characterization and gave highlights from his presentation.

Discussing Trends in New Analtyical Tools for RNA (AAPS PharmSci 360)

Articles

The new Vivaflow SU tangential flow filtration cassette is designed to be more flexible and user-friendly and offers enhanced ultrafiltration and diafiltration efficiency. 

Sartorius Launches Next-Generation TFF Cassette for Streamlining Laboratory Workflows

Freudenberg Medical now offers custom single-use assemblies to expand its offerings in silicone extrusion and molding for biopharma applications.

Freudenberg Adds Custom Single-Use Assemblies to Biopharma Product Portfolio

Raphael Townshend, founder and CEO of Atomic AI,  speaks on AI’s usefulness in characterizing molecular structure and advancing molecular engineering.

BIO 2024: Characterizing and Engineering Molecules with AI  

Andrew Carnegie of Inaphaea BioLabs explains the role of a translational CRO and of PDC models in drug discovery.

Early Analytics with PDC Modeling and Translational CROs (BIO 2024)

Regeneron’s Bari Kowal, senior vice-president, head Development Operations & Portfolio Management, gave insight into how the biopharma industry views the application of AI in R&D.

Exploring the use of AI in R&D at the US Pharma and Biotech Summit

At INTERPHEX 2024, Jay Rajagopalan, senior director—Engineering & Product Management for Malema at PSG Biotech, discussed how the advancement of sensor technologies are being shaped by current industry trends.

Discussing Impact on Sensor Technologies from Industry Trends (INTERPHEX 2024)

John Fuller, PhD, is commercial product manager for Echo Instruments, Beckman Coulter Life Sciences.

NGS abbreviates drug discovery timelines.

Why Automation with the Correct Liquid Handler is Integral to Improved NGS Outcomes

In a non-exclusive licensing agreement, Ricoh will have access to ERS Genomics’ CRISPR/Cas9 genome editing technology to create novel disease models.

Ricoh Licenses CRISPR/Cas9 Technology from ERS Genomics

Ben Moree is principal scientist at Quantum-Si.

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Lab Furnishings and Equipment